Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
What brands are paying to advertise around the World Cup
Sponsorships start at around $15 million and go up to $85 million, with some experts calling $25 million the unofficial barrier of entry to appear on Fox.
Why Dove is betting on hundreds of creators for the World Cup
Dove Men is using hundreds of creators for the World Cup while balancing scale, brand safety and AI concerns.
OpenAI’s ChatGPT ads get its first conversion API partner in LiveRamp
The partnership enables advertisers to connect chatbot ads to real-world purchases for the first time via conversion data.